Clinical Trial Update: Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater [Phase 3]

View source ↗

Summary

Phase 3 study evaluating eye function in patients taking Linezolid for six weeks or longer was terminated, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Optic Neuritis
• Optic Neuropathy

Drugs mentioned

• Linezolid (Linezolid)

Snippet

Sponsor: Pfizer | Conditions: Optic Nerve Diseases | Phase 3 | Status: TERMINATED | Results posted: 2015-06-26